NCI-H1781（人支氣管肺泡腺癌）
CBP60116
詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | NCI-H1781 |
| Background: | The line was established in November 1987. |
| Species: | Homo sapiens, human |
| Tissue: | lung; derived from metastatic site: pleural effusion |
| Disease: | stage 3B,adenocarcinoma; bronchoalveolar carcinoma |
| Gender: | 66 years, female, Caucasian |
| Morphology: | N/A |
| Growth Mode: | adherent |
| Doubling Time: | N/A |
| DNA Profile: | Amelogenin: X CSF1PO: 10 D13S317: 14 D16S539: 8 D5S818: 10 D7S820: 9,10 THO1: 9 TPOX: 10,11 vWA: 14 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS NCI-H1781完全培養(yǎng)基，# CBP60116M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | N/A |
| Receptor Expression: | N/A |
| Oncogene: | N/A |
| Genes Expressed: | N/A |
| Cellular Products: | N/A |
| Tumor Formation: | N/A |
| Immunology: | N/A |
| Comments: | The patient received prior chemotherapy and radiation therapy. The patient was a smoker. For more information, please contact us (4008-750-250). |
